QC
BPMC

Quent Capital’s Blueprint Medicines BPMC Stock Holding History

Quent Capital’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-61
Closed -$5.4K – 408
2025
Q1 		$5.4K Hold
61
– – ﹤0.01% 1003
2024
Q4 		$5.32K Hold
61
– – ﹤0.01% 1026
2024
Q3 		$5.64K Hold
61
– – ﹤0.01% 1082
2024
Q2 		$6.58K Buy
61
+2
+3% +$200 ﹤0.01% 1044
2024
Q1 		$5.6K Hold
59
– – ﹤0.01% 1094
2023
Q4 		$5.44K Hold
59
– – ﹤0.01% 1057
2023
Q3 		$2.96K Buy
59
+18
+44% +$962 ﹤0.01% 1138
2023
Q2 		$2.59K Buy
41
+11
+37% +$598 ﹤0.01% 1157
2023
Q1 		$1.35K Hold
30
– – ﹤0.01% 1209
2022
Q4 		$1.31K Buy
+30
New +$1.44K ﹤0.01% 1197

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quent Capital's BPMC Position: Q2 2025 in Review

Quent Capital sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 61 shares — an estimated $5.4K sold.

Quent Capital first reported a position in BPMC in Q4 2022 and held it in 10 quarters. The position peaked at $6.58K in Q2 2024. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Quent Capital reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Quent Capital sold 61 Blueprint Medicines shares in Q2 2025, an estimated $5.4K.
  • Quent Capital first reported a position in Blueprint Medicines in Q4 2022 and held it in 10 quarters.
  • Quent Capital's Blueprint Medicines position peaked at $6.58K in Q2 2024.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Quent Capital's 13F filing for Q2 2025, filed 21 Jul 2025.